Oct. 23 at 8:15 PM
(NASDAQ:
$IMCC)
IM Cannabis signed a non-binding term sheet to acquire 60% of a quantum computing bio-data company for up to
$54M, using cash, shares, and earn-outs. The deal is subject to due diligence and regulatory approvals and aims to diversify and boost long-term growth.
https://prismmarketview.com/im-cannabis-targets-diversification-with-quantum-bio-data-acquisition/